Ketone urine strips

Ketone urine strips use a color-changing reagent to detect acetoacetate in urine. They do not measure beta-hydroxybutyrate (BHB), blood pH, or bicarbonate.

Medical disclaimer. This article is for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider before starting the ketogenic diet or making changes to your diet, exercise, or medication — especially if you are pregnant or breastfeeding, take medication, or have a medical condition such as diabetes, or kidney, liver, or heart disease. See our editorial & medical-review policy.

What a urine result can show

A positive strip shows that acetoacetate was present in urine collected at that time. Color blocks provide a semiquantitative category rather than a precise current blood-ketone concentration. Hydration, urine concentration, timing, storage, strip expiration, and some medicines can affect the result.

The 2024 DKA consensus notes that nitroprusside urine tests detect acetoacetate but not BHB, the principal ketoacid in DKA. Urine testing may underestimate ketonemia early because acetoacetate formation lags behind BHB. During treatment it may overestimate severity because BHB is converted back to acetoacetate as acidosis improves. Captopril and valproate can also produce false-positive reactions.¹

These limitations are about chemistry and timing. A fading strip does not reliably prove “fat adaptation,” and a negative strip does not establish that DKA is absent.

Urine strips and DKA

The current consensus accepts urine ketones at least 2+ as the ketone component of DKA when blood BHB is unavailable. DKA still requires two other components: diabetes or glucose at least 200 mg/dL, plus venous pH below 7.3 and/or bicarbonate below 18 mmol/L.¹

Because a home strip cannot measure acidosis, it cannot diagnose or exclude DKA on its own. The consensus prefers direct blood BHB measurement for diagnosis and monitoring when available. See blood ketone meter for how that test differs.

Euglycemic DKA occurs with glucose below 200 mg/dL. It is associated with SGLT2 inhibitors, pregnancy, reduced food intake, alcohol-related impaired gluconeogenesis, liver failure, and insulin already taken before testing. The FDA warns that SGLT2-associated ketoacidosis may occur without very high glucose.^1 2

When should urine strips be used?

Some people at risk of DKA are given urine strips as part of an individualized diabetes sick-day plan. That plan should specify when to test, how to interpret the strip, whom to call, and when to seek emergency care. Follow the strip timing and color-chart instructions exactly.

Routine urine testing is generally unnecessary for a ketogenic diet used outside a clinician-directed therapeutic program. Darker is not a health score, and repeatedly trying to maximize the color has no established benefit.

Seek emergency care now for persistent vomiting, severe abdominal pain, deep or difficult breathing, confusion, fainting, or marked drowsiness. These signs are especially concerning for DKA with known or possible diabetes, pregnancy, or SGLT2-inhibitor use; do not wait for very high glucose. Do not delay care because a strip is negative or glucose looks normal.

Frequently Asked Questions

Do urine strips measure BHB?

No. They detect acetoacetate. Blood meters measure BHB, the principal circulating ketoacid in DKA.

Can a negative urine strip rule out DKA?

No. Urine acetoacetate may lag behind blood BHB early in DKA, and a strip cannot measure the metabolic acidosis required for diagnosis.

Does a fading strip prove fat adaptation?

No. Hydration, urine concentration, timing, storage, diet, illness, and changing BHB-to-acetoacetate balance can all affect the result.

Should I use urine strips to maximize ketosis?

No. Routine testing is generally unnecessary for a ketogenic diet, and darker urine ketones do not prove greater fat loss or better health.

See also: BHB · Blood ketone meter · Ketosis · Ketoacidosis (DKA) · Detailed ketosis vs DKA guide · Full glossary

Works cited

1. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report — Umpierrez GE, Davis GM, ElSayed NA, et al., Diabetes Care. 2024;47(8):1257–1275, doi:10.2337/dci24-0032 — August 23, 2026 https://pmc.ncbi.nlm.nih.gov/articles/PMC11272983/
2. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections — U.S. Food and Drug Administration, revised March 15, 2022 — August 23, 2026 https://www.fda.gov/files/drugs/published/FDA-revises-labels-of-SGLT2-inhibitors-for-diabetes-to-include-warnings-about-too-much-acid-in-the-blood-and-serious-urinary-tract-infections.pdf

Article history

1. August 23, 2026Updated
2. August 18, 2026First published